Potential drug–drug interactions in Alzheimer patients with behavioral symptoms

Código QR

Potential drug–drug interactions in Alzheimer patients with behavioral symptoms

Giuseppe Pasqualetti, Sara Tognini, Valeria Calsolaro, Antonio Polini, Fabio Monzani Geriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Abstract: The use of multi drug regimens among the elderly population has increased tremendously over the last decad...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pasqualetti G, Tognini S, Calsolaro V, Polini A, Monzani F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	AChEIs Alzheimer antipsychotic drug-drug interaction Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/2484cc546ad6445195f2d4a7576a8d3d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: María Jesús Friedli, et al.
Publicado: (2021)

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
por: Liang JH, et al.
Publicado: (2018)

Drug prescription appropriateness in the elderly: an Italian study
por: Allegri N, et al.
Publicado: (2017)

Identification of the drug-use behaviors of the elderly living in nursing homes
por: Oguzoncul AF, et al.
Publicado: (2018)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients
por: Tara V. Anand, et al.
Publicado: (2021)

Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)

Effects of Caregiver Dementia Training in Caregiver–Patient Dyads on Psychotropic Drug Prescription: A Randomized Controlled Study
por: Birkenhäger-Gillesse EG, et al.
Publicado: (2021)

Hospitalization in older patients due to adverse drug reactions – the need for a prediction tool
por: Parameswaran Nair N, et al.
Publicado: (2016)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy
por: Bargagli AM, et al.
Publicado: (2019)

Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models
por: Stevenson JM, et al.
Publicado: (2014)

Thyroid function tests before prescribing anti-dementia drugs: a retrospective observational study
por: Sakata N, et al.
Publicado: (2018)

A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting
por: Alhawassi TM, et al.
Publicado: (2014)

Increasing complexity: which drug class to choose for treatment of hypertension in the elderly?
por: Kaiser EA, et al.
Publicado: (2014)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Community-Acquired Acute Kidney Injury Induced By Drugs In Older Patients: A Multifactorial Event
por: Robert L, et al.
Publicado: (2019)

Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery
por: Lakey-Beitia J, et al.
Publicado: (2017)

Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts AG, et al.
Publicado: (2018)

The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting
por: Ruangritchankul S, et al.
Publicado: (2020)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
por: Moretti DV
Publicado: (2016)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Management of the behavioral and psychological symptoms of dementia
por: Elizabeth C Hersch, et al.
Publicado: (2008)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Preferences and attitudes of older adults of Bialystok, Poland toward the use of over-the-counter drugs
por: Cybulski M, et al.
Publicado: (2018)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Drug prescription appropriateness in the elderly: an Italian study [Corrigendum]
por: Allegri N, et al.
Publicado: (2017)

Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α
por: Toledo JO, et al.
Publicado: (2015)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)